{"title":"诺华ILAR风湿病奖2001骨关节炎:从分子到人。","authors":"Jean-Pierre Pelletier, Johanne Martel-Pelletier","doi":"10.1186/ar378","DOIUrl":null,"url":null,"abstract":"<p><p>During our careers, we have developed new and innovative concepts pertaining to the pathophysiology of osteoarthritis which have assisted in the development of new therapeutic approaches. Moreover, our laboratory has long sought to develop protective agents for osteoarthritic structural joint tissues. The most significant concepts that have originated from our lab are briefly outlined in this commentary.</p>","PeriodicalId":101361,"journal":{"name":"Arthritis research","volume":"4 1","pages":"13-9"},"PeriodicalIF":0.0000,"publicationDate":"2002-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/ar378","citationCount":"14","resultStr":"{\"title\":\"The Novartis-ILAR Rheumatology Prize 2001 Osteoarthritis: from molecule to man.\",\"authors\":\"Jean-Pierre Pelletier, Johanne Martel-Pelletier\",\"doi\":\"10.1186/ar378\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>During our careers, we have developed new and innovative concepts pertaining to the pathophysiology of osteoarthritis which have assisted in the development of new therapeutic approaches. Moreover, our laboratory has long sought to develop protective agents for osteoarthritic structural joint tissues. The most significant concepts that have originated from our lab are briefly outlined in this commentary.</p>\",\"PeriodicalId\":101361,\"journal\":{\"name\":\"Arthritis research\",\"volume\":\"4 1\",\"pages\":\"13-9\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2002-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1186/ar378\",\"citationCount\":\"14\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Arthritis research\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1186/ar378\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2001/11/2 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Arthritis research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1186/ar378","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2001/11/2 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
The Novartis-ILAR Rheumatology Prize 2001 Osteoarthritis: from molecule to man.
During our careers, we have developed new and innovative concepts pertaining to the pathophysiology of osteoarthritis which have assisted in the development of new therapeutic approaches. Moreover, our laboratory has long sought to develop protective agents for osteoarthritic structural joint tissues. The most significant concepts that have originated from our lab are briefly outlined in this commentary.